2020
DOI: 10.3389/fncel.2020.00122
|View full text |Cite
|
Sign up to set email alerts
|

Multimodal Analysis of STRADA Function in Brain Development

Abstract: mTORopathies are a heterogeneous group of neurological disorders characterized by malformations of cortical development (MCD), enhanced cellular mechanistic target of rapamycin (mTOR) signaling, and epilepsy that results from mutations in mTOR pathway regulatory genes. Homozygous mutations (del exon 9-13) in the pseudokinase STE20related kinase adaptor alpha (STRAD-α; STRADA), an mTOR modulator, are associated with Pretzel Syndrome (PS), a neurodevelopmental disorder within the Old Order Mennonite Community ch… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 12 publications
(18 citation statements)
references
References 20 publications
(38 reference statements)
1
17
0
Order By: Relevance
“…Newer rodent models using IUE to focally express or suppress mTORC1 pathway regulating genes in the cortex (discussed more below), as well as Tsc2 and Depdc5 zebrafish models (Kim S. H. et al, 2011;de Calbiac et al, 2018;Swaminathan et al, 2018), also recapitulate many of the mTORopathy phenotypes. Recent models also include patient-derived induced pluripotent stem cells (IPSCs) and cortical organoids, which provide the advantage of studying mTOR function in human cell populations (Blair et al, 2018;Andrews et al, 2020;Dang et al, 2020;Eichmüller et al, 2020). Both transgenic and IUE-based animal models as well as in vitro models have been vital for mechanistic and preclinical drug studies.…”
Section: Designing Animal Models Of Mtoropathiesmentioning
confidence: 99%
“…Newer rodent models using IUE to focally express or suppress mTORC1 pathway regulating genes in the cortex (discussed more below), as well as Tsc2 and Depdc5 zebrafish models (Kim S. H. et al, 2011;de Calbiac et al, 2018;Swaminathan et al, 2018), also recapitulate many of the mTORopathy phenotypes. Recent models also include patient-derived induced pluripotent stem cells (IPSCs) and cortical organoids, which provide the advantage of studying mTOR function in human cell populations (Blair et al, 2018;Andrews et al, 2020;Dang et al, 2020;Eichmüller et al, 2020). Both transgenic and IUE-based animal models as well as in vitro models have been vital for mechanistic and preclinical drug studies.…”
Section: Designing Animal Models Of Mtoropathiesmentioning
confidence: 99%
“…To better understand the role of STRADA in human neural development and disease, a human-based model is needed to complement the animal models. Previously, we generated induced pluripotent stem cells (iPSCs) from two individuals with PMSE and differentiated them into cortical-like excitatory neurons in monolayer cultures (Dang et al, 2020). We found loss of STRADA expression, increased pS6 expression, and neuronal cytomegaly, validating that the iPSC neuron model of PMSE demonstrates mTORC1 hyperactivity.…”
Section: Introductionmentioning
confidence: 60%
“…Fibroblasts were isolated from skin biopsies of two female individuals with PMSE and reprogrammed into iPSCs as previously described (Dang et al, 2020). One iPSC line from each of the two individuals with PMSE was used in this study.…”
Section: Human Subjectsmentioning
confidence: 99%
See 2 more Smart Citations